Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALFACALCIDOL Cause C-reactive protein abnormal? 35 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 35 reports of C-reactive protein abnormal have been filed in association with ALFACALCIDOL. This represents 3.8% of all adverse event reports for ALFACALCIDOL.

35
Reports of C-reactive protein abnormal with ALFACALCIDOL
3.8%
of all ALFACALCIDOL reports
34
Deaths
35
Hospitalizations

How Dangerous Is C-reactive protein abnormal From ALFACALCIDOL?

Of the 35 reports, 34 (97.1%) resulted in death, 35 (100.0%) required hospitalization, and 35 (100.0%) were considered life-threatening.

Is C-reactive protein abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALFACALCIDOL. However, 35 reports have been filed with the FAERS database.

What Other Side Effects Does ALFACALCIDOL Cause?

Off label use (145) Maternal exposure during pregnancy (120) Headache (118) Pyrexia (118) Lower respiratory tract infection (114) Condition aggravated (109) Fatigue (101) Folliculitis (101) Dyspnoea (97) Hypersensitivity (95)

What Other Drugs Cause C-reactive protein abnormal?

METHOTREXATE (3,734) ADALIMUMAB (3,629) ETANERCEPT (3,592) ABATACEPT (3,402) LEFLUNOMIDE (3,279) TOCILIZUMAB (3,259) HYDROXYCHLOROQUINE (3,245) SULFASALAZINE (2,823) INFLIXIMAB (2,676) RITUXIMAB (2,608)

Which ALFACALCIDOL Alternatives Have Lower C-reactive protein abnormal Risk?

ALFACALCIDOL vs ALFENTANIL ALFACALCIDOL vs ALFUZOSIN ALFACALCIDOL vs ALGLUCOSIDASE ALFA ALFACALCIDOL vs ALIMTA ALFACALCIDOL vs ALIROCUMAB

Related Pages

ALFACALCIDOL Full Profile All C-reactive protein abnormal Reports All Drugs Causing C-reactive protein abnormal ALFACALCIDOL Demographics